Загрузка...
Why not treat human cancer with interleukin-1 blockade?
The clinical successes of targeting angiogenesis provide a basis for trials of interleukin-1 (IL-1) blockade and particularly anti-IL-1β as an add-on therapy in human metastatic disease. In animal studies for over 20 years, IL-1 has been demonstrated to increase adherence of tumor cells to the endot...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2865633/ https://ncbi.nlm.nih.gov/pubmed/20422276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-010-9229-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|